Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Lancet Diabetes Endocrinol. 2015 Sep 17;3(11):855–865. doi: 10.1016/S2213-8587(15)00290-9

Figure 2. Mean Annual Prescription Drug Costs from Year 0 to 15 (Years 0–6: Questionnaire data; Years 7–15: Register data from the Prescribed Drug Register, data capture 2005–2013).

Figure 2

Adjusted for baseline age, sex, smoking, body mass index and inclusion period (</≥ 1995), and drug costs the year prior to the index date (year 0). Error bars indicate 95%CIs derived by nonparametric bootstrapping. Data were not collected in year 5 and therefore no data are presented. Results are based on observed data. Imputed vs observed data are shown in eFigure 2. *Self-reported drug data collected for follow-up years 0–6 (left) and Swedish Prescribed Drug Register data for follow-up years 7–15 (2005–2013) (right). Costs are reported in 2013 US$.